Home›People›Randall Moreadith
RM

Randall Moreadith

Chief Scientific Officer at Serina Therapeutics.

ExecutiveDirectorPublic company
Updated Nov 9, 2026·Latest SEC filing May 26, 2026·Suggest an edit

About Randall Moreadith

Randall Moreadith is a chief scientific officer at Serina Therapeutics.

Randall Moreadith reports to the SEC as an officer of 2 public companies, including Gene Biotherapeutics (CRXM).

Randall Moreadith first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Randall Moreadith in the role, so the role may have started earlier or lasted longer.

Serina Therapeutics, Inc.
Chief Scientific Officer
2012 – 2026 · Public company (SER)
Gene Biotherapeutics, Inc.
Exec VP and Chief Med Officer
2006 – 2008 · Public company (CRXM)

Key Colleagues at Startups

The people Randall Moreadith works with at each company, as listed on that company's latest Form D.

Serina Therapeutics, Inc. · Form D, Mar 30, 2023
BF
Barbara Fisk
Director
SL
Steve Ledger
Director
JH
J Harris
Executive officer and director
TV
Tacey Viegas
Executive officer
MB
Michael Bentley
Executive officer and director

Sources

  1. SECSerina Therapeutics, Inc. Form D, filed Mar 30, 2023
  2. SECForms 3, 4 and 5 filed by Randall Moreadith (SEC filer 1301120)